The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis (Q28475461)

20 October 2023

Leonard Amaral

6

Leonard

Amaral

1 reference

20 October 2023

Jakko van Ingen

7

Jakko

van Ingen

1 reference

20 October 2023

8

Martin J Boeree

Martin J

Boeree

1 reference

20 October 2023

5

Cecile Magis-Escurra

Cecile

Magis-Escurra

1 reference

20 October 2023

author name string

Rogelio Hernandez-Pando

series ordinal

2

author given names

Rogelio

author last names

Hernandez-Pando

1 reference

20 October 2023

Hector Orozco

series ordinal

3

author given names

Hector

author last names

Orozco

1 reference

20 October 2023

Diana Aguilar

series ordinal

4

author given names

Diana

author last names

Aguilar

1 reference

Creative Commons Attribution 4.0 International

20 October 2023

language of work or name

English

0 references

publication date

9 September 2010

0 references

published in

PLOS One

0 references

volume

5

0 references

issue

9

0 references

page(s)

e12640

0 references

copyright license

start time

9 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A Mycobacterium tuberculosis sigma factor network responds to cell-envelope damage by the promising anti-mycobacterial thioridazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

The curative activity of thioridazine on mice infected with Mycobacterium tuberculosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

New tuberculosis therapeutics: a growing pipeline

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Experiments to Illustrate The Effect Of Chlorpromazine On The Permeability Of The Bacterial Cell Wall

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2936563

Thioridazine induces lipid peroxidation in myelin of rat brain

2 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012640

Transfer factors as immunotherapy and supplement of chemotherapy in experimental pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012640

16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012640

Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012640

Effect of phenothiazines on protein kinase C- and calcium-dependent activation of peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012640

In vitro activity of thioridazine against mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0012640

Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis

21 January 2018

1 reference

12 December 2020

Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice

1 reference

12 December 2020

The Use of Fluorescein Diacetate and Ethidium Bromide as a Stain for Evaluating Viability of Mycobacteria

1 reference

12 December 2020

Clinical, biochemical and post mortem studies on a patient treated with chlorpromazine

1 reference

12 December 2020

A combination of a transforming growth factor-beta antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0012640

Identifiers

DOI

1 reference

ADS bibcode

2010PLoSO...512640V

0 references

1 reference

1 reference

1 reference